Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/EBIT(x) 5.369.545.8346.42-77.79

What is the latest EV/EBIT ratio of VENUS REMEDIES ?

The latest EV/EBIT ratio of VENUS REMEDIES is 5.36 based on Mar2023 Consolidated results.
Year EV/EBIT
Mar20235.36
Mar20229.54
Mar20215.83
Mar202046.42
Mar2019-77.79

How is EV/EBIT of VENUS REMEDIES Trending?

Years EV/EBIT % Change
Mar2023 5.36
-43.82
Mar2022 9.54
63.64
Mar2021 5.83
-87.44
Mar2020 46.42
Positive
Mar2019 -77.79 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/EBIT ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹399.3 Cr -2.8% -12.1% 48.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 1.6% -3.7% 60% Stock Analytics
CIPLA ₹109,559.0 Cr -2% -4.6% 49.9% Stock Analytics
DIVIS LABORATORIES ₹103,416.0 Cr -0.9% 4.2% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr -2.1% -0.9% 89.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -3.1% -4.7% 21.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.8%

-12.1%

48.5%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses